Induction of hyperproliferative fetal megakaryopoiesis by an N-terminally truncated GATA1 mutant

Genes to Cells

Volumn 14, Issue 9, 2009, Pages 1119-1131

  Shimizu, Ritsuko ^a   Kobayashi, Eri ^a   Engel, James Douglas ^b   Yamamoto, Masayuki ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR GATA 1;

ACUTE MEGAKARYOCYTIC LEUKEMIA; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BONE MARROW; CELL FRACTIONATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; DOWN SYNDROME; EMBRYO; ERYTHROID CELL; ERYTHROLEUKEMIA; FETUS; GENE EXPRESSION; GENE FUNCTION; GENE INDUCTION; GENE MUTATION; LEUKEMOGENESIS; LIVER; MEGAKARYOCYTE; MEGAKARYOPOIESIS; MICROENVIRONMENT; MOUSE; MYELOPROLIFERATIVE DISORDER; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; SPLEEN; TRANSGENIC MOUSE;

ANIMALS; BONE MARROW; CELL DIFFERENTIATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOWN SYNDROME; EMBRYO, MAMMALIAN; FEMALE; FETAL DISEASES; GATA1 TRANSCRIPTION FACTOR; HUMANS; LEUKEMIA, MEGAKARYOBLASTIC, ACUTE; MEGAKARYOCYTES; MICE; MICE, TRANSGENIC; MUTATION; MYELOPROLIFERATIVE DISORDERS;

MUS;

EID: 69849088569     PISSN: 13569597     EISSN: 13652443     Source Type: Journal    
DOI: 10.1111/j.1365-2443.2009.01338.x     Document Type: Article

References (35)

1. Ahmed, M., Sternberg, A., Hall, G., Thomas, A., Smith, O., O'Marcaigh, A., Wynn, R., Stevens, R., Addison, M., King, D., Stewart, B., Gibson, B., Roberts, I. & Vyas, P. (2004) Natural history of GATA1 mutations in Down syndrome. Blood 103, 2480-2489.
2. Bozner, P. (2002) Transient myeloproliferative disorder with erythroid differentiation in Down syndrome. Arch. Pathol. Lab. Med. 126, 474-477.
3. Calligaris, R., Bottardi, S., Cogoi, S., Apezteguia, I. & Santoro, C. (1995) Alternative translation initiation site usage results in two functionally distinct forms of the GATA-1 transcription factor. Proc. Natl Acad. Sci. USA 92, 11598-11602.
4. Chang, A.N., Cantor, A.B., Fujiwara, Y., Lodish, M.B., Droho, S., Crispino, J.D. & Orkin, S.H. (2002) GATA-factor dependence of the multitype zinc-finger protein FOG-1 for its essential role in megakaryopoiesis. Proc. Natl Acad. Sci. USA 14, 9237-9242.
5. Dubart, A., Romeo, P.H., Vainchenker, W. & Dumenil, D. (1996) Constitutive expression of GATA-1 interferes with the cell-cycle regulation. Blood 87, 3711-3721.
6. Fujiwara, Y., Browne, C.P., Cunniff, K., Goff, S.C. & Orkin, S.H. (1996) Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1. Proc. Natl Acad. Sci. USA 93, 12355-12358.
7. Greene, M.E., Mundschau, G., Wechsler, J., McDevitt, M., Gamis, A., Karp, J., Gurbuxani, S., Arceci, R. & Crispino, J.D. (2003) Mutations in GATA1 in both transient myeloproliferative disorder and acute megakaryoblastic leukemia of Down syndrome. Blood Cells Mol. Dis. 31, 351-356.
8. Harigae, H., Xu, G., Sugawara, T., Ishikawa, I., Toki, T. & Ito, E. (2004) The GATA1 mutation in an adult patient with acute megakaryoblastic leukemia not accompanying Down syndrome. Blood 103, 3242-3243.
9. Hitzler, J.K., Cheung, J., Li, Y., Scherer, S.W. & Zipursky, A. (2003) GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome. Blood 101, 4301-4304.
10. Hollanda, L.M., Lima, C.S., Cunha, A.F., Albuquerque, D.M., Vassallo, J., Ozelo, M.C., Joazeiro, P.P., Saad, S.T. & Costa, F.F. (2006) An inherited mutation leading to production of only the short isoform of GATA-1 is associated with impaired erythropoiesis. Nat. Genet. 18, 807-812.
11. Holmes, D.K., Bates, N., Murray, M., Ladusans, E.J., Morabito, A., Bolton-Maggs, P.H., Johnston, T.A., Walkenshaw, S., Wynn, R.F. & Bellantuono, I. (2006) Hematopoietic progenitor cell deficiency in fetuses and children affected by Down's syndrome. Exp. Hematol. 34, 1611-1615.
12. Ito, E., Kasai, M., Hayashi, Y., Toki, T., Arai, K., Yokoyama, S., Kato, K., Tachibana, N., Yamamoto, M. & Yokoyama, M. (1995) Expression of erythroid-specific genes in acute megakaryoblastic leukaemia and transient myeloproliferative disorder in Down's syndrome. Br. J. Haematol. 90, 607-614.
13. Ito, E., Toki, T., Ishihara, H., Ohtani, H., Gu, L., Yokoyama, M., Engel, J.D. & Yamamoto, M. (1993) Erythroid transcription factor GATA-1 is abundantly transcribed in mouse testis. Nature 362, 466-468.
14. Karandikar, N.J., Aquino, D.B., McKenna, R.W. & Kroft, S.H. (2001) Transient myeloproliferative disorder and acute myeloid leukemia in Down syndrome. An immunophenotypic analysis. Am. J. Clin. Pathol. 116, 204-210.
15. Kaushansky, K. (1995) Thrombopoietin: The primary regulator of platelet production. Blood 86, 419-431.
16. Kuhl, C., Atzberger, A., Iborra, F., Nieswandt, B., Porcher, C. & Vyas, P. (2005) GATA1-mediated megakaryocyte differentiation and growth control can be uncoupled and mapped to different domains in GATA1. Mol. Cell. Biol. 25, 8592-8606.
17. Levine, R.F. & Fedorko, M.E. (1976) Isolation of intact megakaryocytes from guinea pig femoral marrow. Successful harvest made possible with inhibitions of platelet aggregation; enrichment achieved with a two-step separation technique. J. Cell Biol. 69, 159-172.
18. Li, Z., Godinho, F.J., Klusmann, J.H., Garriga-Canut, M., Yu, C. & Orkin, S.H. (2005) Developmental stage-selective effect of somatically mutated leukemogenic transcription factor GATA1. Nat. Genet. 37, 613-619.
19. Massey, G.V. (2005) Transient leukemia in newborns with Down syndrome. Pediatr. Blood Cancer 44, 29-32.
20. Nishimura, S., Takahashi, S., Kuroha, T., Suwabe, N., Nagasawa, T., Trainor, C. & Yamamoto, M. (2000) A GATA box in the GATA-1 gene hematopoietic enhancer is a critical element in the network of GATA factors and sites that regulate this gene. Mol. Cell. Biol. 20, 713-723.
21. Onodera, K., Takahashi, S., Nishimura, S., Ohta, J., Motohashi, H., Yomogida, K., Hayashi, N., Engel, J.D. & Yamamoto, M. (1997) GATA-1 transcription is controlled by distinct regulatory mechanisms during primitive and definitive erythropoiesis. Proc. Natl Acad. Sci. USA 94, 4487-4492.
22. Pan, X., Ohneda, O., Ohneda, K., Lindeboom, F., Iwata, F., Shimizu, R., Nagano, M., Suwabe, N., Philipsen, S., Lim, K.C., Engel, J.D. & Yamamoto, M. (2005) Graded levels of GATA-1 expression modulate survival, proliferation and differentiation of erythroid progenitors. J. Biol. Chem. 6, 22385-22394.
23. Rainis, L., Bercovich, D., Strehl, S., Teigler-Schlegel, A., Stark, B., Trka, J., Amariglio, N., Biondi, A., Muler, I., Rechavi, G., Kempski, H., Haas, O.A. & Izraeli, S. (2003) Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21. Blood 102, 981-986.
24. Shimizu, R., Engel, J.D. & Yamamoto, M. (2008) GATA1-related leukaemias. Nat. Rev. Cancer 8, 279-287.
25. Shimizu, R., Kuroha, T., Ohneda, O., Pan, X., Ohneda, K., Takahashi, S., Philipsen, S. & Yamamoto, M. (2004a) Leukemogenesis caused by incapacitated GATA-1 function. Mol. Cell. Biol. 24, 10814-10825.
26. Shimizu, R., Ohneda, K., Engel, J.D., Trainor, C.D. & Yamamoto, M. (2004b) Transgenic rescue of GATA-1-deficient mice with GATA-1 lacking a FOG-1 association site phenocopies patients with X-linked thrombocytopenia. Blood 103, 2560-2567.
27. Shimizu, R., Takahashi, S., Ohneda, K., Engel, J.D. & Yamamoto, M. (2001) In vivo requirements for GATA-1 functional domains during primitive and definitive erythropoiesis. EMBO J. 20, 5250-5260.
28. Takahashi, S., Onodera, K., Motohashi, H., Suwabe, N., Hayashi, N., Yanai, N., Nabesima, Y. & Yamamoto, M. (1997) Arrest in primitive erythroid cell development caused by promoter-specific disruption of the GATA-1 gene. J. Biol. Chem. 272, 12611-12615.
29. Tober, J., Koniski, A., McGrath, K.E., Vemishetti, R., Emerson, R., de Mesy-Bentley, K.K., Waugh, R. & Palis, J. (2007) The megakaryocyte lineage originates from hemangioblast precursors and is an integral component both of primitive and of definitive hematopoiesis. Blood 109, 1433-1441.
30. Ugazio, A.G., Maccario, R., Notarangelo, L.D. & Burgio, G.R. (1990) Immunology of Down syndrome: A review. Am. J. Med. Genet. Suppl. 7, 204-212.
31. Vannucchi, A.M., Bianchi, L., Cellai, C., Paoletti, F., Rana, R.A., Lorenzini, R., Migliaccio, G. & Migliaccio, A.R. (2002) Development of myelofibrosis in mice genetically impaired for GATA-1 expression (GATA-1(low) mice). Blood 100, 1123-1132.
32. Wechsler, J., Greene, M., McDevitt, M.A., Anastasi, J., Karp, J.E., Le Beau, M.M. & Crispino, J.D. (2002) Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome. Nat. Genet. 12, 1-5.
33. Weiss, M.J. & Orkin, S.H. (1995) Transcription factor GATA-1 permits survival and maturation of erythroid precursors by preventing apoptosis. Proc. Natl Acad. Sci. USA 92, 9623-9627.
34. Xu, M.J., Matsuoka, S., Yang, F.C., Ebihara, Y., Manabe, A., Tanaka, R., Eguchi, M., Asano, S., Nakahata, T. & Tsuji, K. (2001) Evidence for the presence of murine primitive megakaryocytopoiesis in the early yolk sac. Blood 97, 2016-2022.
35. Zipursky, A. (2003) Transient leukaemia - a benign form of leukaemia in newborn infants with trisomy 21. Br. J. Haematol. 120, 930-938.